Skip to main content
OpenTrials
Completed

NCT Number: NCT06088693

The Role of Electroacupuncture With Standard Therapy on Sperm Analysis and SOD Levels in Oligozoospermia.

The goal of this clinical trial is to compare in Oligozoospermia Patient. The main questions it aims to answer are: 1. Electroacupuncture therapy and standard therapy can affect oligozoospermia. 2. Electroacupuncture therapy and standard therapy can affect semen and spermatozoa plasma SOD levels.

Researchers will compare patient with standard therapy with patient with standard therapy with electroacupuncture.

Completed

Looking for future studies?

Notify Me

Key information

Age range

25 year–45 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Lisa Yunita

Jakarta, Jakarta Timur, 13210, Indonesia

About this study

  • Male subjects aged more than 25 years and less than 45 years.
  • Oligozoospermia according to the 2010 WHO criteria is mild (10-15 million spermatozoa/mL), moderate (5-10 million spermatozoa/mL) and severe (<5 million spermatozoa/mL).
  • Willing to take part in research and sign informed consent.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male 25 to 45 years old.
  • Oligozoospermia according to the 2010 WHO criteria is mild (10-15 million spermatozoa/mL), moderate (5-10 million spermatozoa/mL) and severe (<5 million spermatozoa/mL).
  • Willing to participate in research and sign informed consent.

Exclusion criteria

  • Emergency case patient / bleeding disorders
  • Have a tumor, scar tissue or infected wound in the area where the acupuncture needle will be inserted.
  • Alcoholic
  • Using a pacemaker (heart pacemaker).
  • Azoospermia
  • Varicocele

Treatment and study plan

Electroacupuncture and Standard Therapy

Other

Acupuncture Needle Insertion with Electroacupuncture machine.

Primary outcomes

  1. Sperm analysis

    Time frame: Before Treatment in day 1, After 30 days of treatment.

    Spermatozoa/mL

  2. SOD Spermatozoa

    Time frame: Before Treatment in day 1, After 30 days of treatment.

    Superokside Dismutase in Spermatozoa

  3. SOD Plasma Semen

    Time frame: Before Treatment in day 1, After 30 days of treatment.

    Superokside Dismutase in Plasma Semen

Sponsors and collaborators

Lead sponsor

Indonesia University

Other

Registry information

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Oct 18, 2023
Registry last updated
Dec 28, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.